All posts by imreal

Christine A. DiEdwardo Named a Castle Connolly Top Doctor for 2023


Dr. Christine DiEdwardo

Christine A. DiEdwardo, MD, FACS

“My goal is to have the patient look very natural. If it’s facial fillers, then I want to put a small amount of product in the correct area in that patient. I want them to look younger, but not like they have had any filler or injection.”

Christine A. DiEdwardo, MD, FACS, has been named a 2023 Castle Connolly Top Doctor in the area of cosmetic plastic surgery. Castle Connolly Top Doctors are peer-nominated, and thoroughly vetted by a physician-led research team. The list honors “best-in-class healthcare providers, who embody excellence in clinical care and interpersonal skills,” according to Castle Connolly, and represents the top 7% of all U.S. practicing physicians.

With over two decades of experience, Dr. DiEdwardo specializes in a wide range of cosmetic surgical and non-surgical treatments, including breast augmentation, facelifts, liposuction, rhinoplasty, body contouring, labiaplasty and women’s wellness treatments. She has achieved verified Expert Injector(TM) status, having performed thousands of procedures with cosmetic injectable products, such as Botox® and Restylane® for facial rejuvenation. Less than 3% of physicians are qualified to be an Expert Injector. Dr. DiEdwardo is known for her friendly bedside manner, attention to detail, and dedication to delivering natural-looking results. She joined the highly respected boutique practice of Christine Hamori Cosmetic Surgery + Skin Spa on Boston’s South Shore in 2021 after serving as senior staff at Lahey Hospital and Medical Center, and medical director of the Lahey Center for Cosmetic and Laser Surgery in Lexington, Massachusetts.

Regarding her work with surgery and facial fillers, Dr. DiEdwardo says, “My goal is to have the patient look very natural. If it’s facial fillers, then I want to put a small amount of product in the correct area in that patient. I want them to look younger, but not like they have had any filler or injection.”

Dr. DiEdwardo earned her medical degree from Boston University School of Medicine and served a comprehensive residency in plastic and reconstructive surgery at University of Pittsburgh Medical Center/UPMC. She remains at the forefront of the latest advancements in her field, ensuring that her patients receive the most advanced and effective treatments available.

About Christine Hamori Cosmetic Surgery + Skin Spa:

Christine Hamori Cosmetic Surgery + Skin Spa is a state-of-the-art plastic surgery practice located in Duxbury, Massachusetts. Founded in 2000 by Christine A. Hamori, MD, FACS (also a Castle Connolly Top Doctor), the practice offers a comprehensive range of surgical and non-surgical procedures to help patients enhance their natural beauty and improve their self-confidence. With a commitment to personalized care, leading-edge technology, and natural looking results, Christine Hamori Cosmetic Surgery + Skin Spa is a trusted destination for individuals seeking exceptional aesthetic treatments serving patients from across Massachusetts and beyond.

https://www.christinehamori.com

About Castle Connolly:

With over 30 years’ experience researching, reviewing and selecting Top Doctors, Castle Connolly is a trusted and credible source. Castle Connolly’s peer-reviewed directory is the premier rating body whose methodology is found to be more reliable in identifying quality of care than sites based solely on patient reviews.

Share article on social media or email:

New Legislation Aims to Expand Access to Clean Cooking Globally


“Our bill aims to address a serious global public health and environmental issue where leadership by the United States can make a real difference,” said Senator Susan Collins.

Senator Susan Collins (R-ME) and Senator Dick Durbin (D-IL) have introduced the Clean Cooking Support Act. The bipartisan bill would improve global health and reduce climate-harming emissions by helping people in low- and middle-income countries gain access to cleaner-burning fuels and stoves for cooking.

Currently, some 2.3 billion people—nearly a third of the world’s population—rely on open fires or heavily-polluting stoves and fuels to cook their meals. The resulting air pollution, which is at similar levels to the global aviation and shipping industries, contributes to 3.2 million premature deaths every year and costs the world more than US $2.4 trillion in economic impact. Helping people switch to more modern stoves and fuels such as electricity, solar power, gas, and biofuels can improve health, environmental sustainability, and the climate, among other benefits.

With support from a broad coalition of businesses, research institutions, and advocacy organizations, the bill would accelerate clean cooking financing, research, market development, technological standards, and support to countries’ carbon emissions reductions plans. The bill would also create a much-needed Interagency Working Group, chaired by the offices of the Secretary of State and the Administrator of the U.S. Agency for International Development, to work with organizations including the Clean Cooking Alliance to increase global access to clean cooking fuels and technologies.

“Our bill aims to address a serious global public health and environmental issue where leadership by the United States can make a real difference. It would directly benefit some of the world’s poorest people, including the women and girls who are disproportionately affected, and reduce harmful pollution that affects us all,” said Senator Susan Collins. “I urge my colleagues to join me and Senator Durbin in supporting the Clean Cooking Support Act.”

“Emissions from combustion-based cooking appliances can cause lung cancer, exacerbate respiratory diseases, lead to heart attacks and strokes, and even cause premature death,” said Harold Wimmer, President & CEO of the American Lung Association, in a press release from Senator Collins. “Transitioning to cleaner forms of cooking will have immediate health benefits, particularly for women and children who often bear the brunt of this pollution exposure globally.”

Between 2010 and 2021, more than a billion people gained access to clean cooking, which represents significant progress considering the multi-billion-dollar funding shortfall for addressing this global crisis. However, much more needs to be done to reach universal access to clean cooking. Without urgent action to accelerate progress and investment, nearly 2 billion people will still rely on polluting, inefficient stoves and fuels in 2030, with the access gap in sub-Saharan Africa being particularly acute.

“We cannot reach our shared development and climate goals without addressing access to clean energy for cooking,” said Dymphna van der Lans, Chief Executive Officer of the Clean Cooking Alliance. “It is one of the most under-invested environmental health challenges and, unless we make meaningful changes, some 1.9 billion people will still be without access to clean cooking in 2030. I am grateful to Senator Collins and Senator Durbin for taking action on this critical issue. This legislation is an important step toward improving the health of millions and helping to right a climate and energy injustice.”

The Clean Cooking Alliance is working with partners around the world to improve access to clean cooking, including through:

-The Responsible Carbon Finance for Clean Cooking Initiative, which seeks to ensure that carbon market opportunities are realized through sound, verifiable, and up-to-date methodologies.

-The Clean Cooking and Climate Consortium, which supports countries’ efforts in using clean cooking interventions to meet their climate goals.

-The Delivery Units Network, which helps governments achieve their clean cooking plans.

-The Spark+ Africa Fund, which finances pioneering clean cooking companies.

Endorsing the Clean Cooking Support Act 

A growing coalition of businesses, research institutions, and advocacy organizations have signed on to support this new legislation, including:

American Heart Association

American Lung Association

Better World Campaign

Boston College Global Observatory of Pollution and Health

Burn Design Lab

BURN USA

Chef Jose Andres

CLASP (Collaborative Labeling and Appliance Standards Program)

Clean Cooking Alliance

ENERGIA International Network on Gender and Sustainable Energy

Every Breath Counts Coalition

Global Women’s Network for Energy Transition

Pivot Energy

Project Gaia

Solar Cookers International

Spark+ Fund Africa

Sustainable Energy for All

Student Energy

United Nations Association – USA

University of Chicago Center for Global Health

Value for Women

Whitten & Roy Partnership

World Central Kitchen

World LPG Association

To add your organization, please contact info@cleancooking.org.

Share article on social media or email:

Intus Bio Strengthens Industry Leading Microbiome Platform with Acquisition of Pattern Genomics


News Image

Intus Biosciences, LLC(Intus Bio), creators of the industry-leading Titan-1™ microbiome research and testing platform, has announced the strategic acquisition of Pattern Genomics, a developer of advanced genomic analysis software tools. This transaction was made possible with the support of Connecticut Innovations, an investor in both companies.

The development enhances Intus Bio’s portfolio of end-to-end data-driven solutions for microbiome discovery and understanding. The company has a long history of collaboration with Pattern Genomics and a deep appreciation of the technology being acquired.

The Intus Bio Titan-1™ platform combines patented assays and next-generation proprietary analysis tools for an unprecedented ability to generate high accuracy, high-resolution strain-level data on a high-throughput basis. The integration of Pattern Genomics’ technology brings additional machine learning tools for biomarker discovery and patient stratification, across extensive datasets and populations.

As part of the transaction, Pattern Genomics Founder and President, Daniel Fasulo has joined Intus Bio as Head of IT and Bioinformatics.

“We’re grateful for the support of Connecticut Innovations, as we add the impressive technology of Pattern Genomics to Intus Bio. Together, we have an unmatched ability to produce and analyze high-resolution bacterial data at scale, creating incredible opportunities across every aspect of healthcare” said Paul Denslow, Intus Bio’s CEO. “We are also very pleased to have Dan join the Intus Bio leadership team, as he’s a fantastic addition we already know well.”

“After nearly 11 years of developing a portfolio of bioinformatics technologies at Pattern Genomics, I am thrilled with this transaction and to join the Intus Bio team,” said Daniel Fasulo, President of Pattern Genomics. “There is no better home for Pattern than Intus Bio, as they bring microbiome technologies into practical medical and pharmaceutical applications.”

“Intus Bio has acquired a powerful asset in Pattern, adding to their already impressive and groundbreaking Titan-1™ assay and analysis platform,” said Dan Wagner, Senior Managing Director of Investments at Connecticut Innovations. “The exciting combination of these technologies only increases their significant potential to impact the healthcare industry. We look forward to being part of Intus Bio’s future success.”

About Intus Biosciences, LLC:

Intus Bio has developed world-leading technology to identify bacteria and deliver answers about the microbiome with unprecedented detail, accuracy, and scale. Its patented and validated Titan-1TM platform combines high-throughput assay and analysis technology to generate strain-level information. The company provides advanced research and commercial services across global pharmaceutical, diagnostic, and testing industries; is active in health, agricultural, and environmental fields; and continually develops new partnerships, technologies, and applications.

About Pattern Genomics, LLC:

Founded in 2011, Pattern Genomics has developed sophisticated bioinformatics tools that seek to uncover patterns and key biomarkers from massive genomic data sets. The technology, when combined with next-generation sequencing, powers efficient, data-driven processes that can be applied to a broad range of health and diagnostic problems.

About Connecticut Innovations:

Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. CI provides venture capital and strategic support for early-stage technology companies, financial support for innovation and collaboration, and connections to its well-established network of partners and professionals.

To learn more or to partner with Intus Biosciences, visit intusbio.com.

Share article on social media or email:

Breaking Access Barriers, Optimizing Protocols and Navigating Regulatory Challenges, Upcoming Webinar Hosted by Xtalks


These topics have become increasingly important as the continued development of precision medicines has led to smaller study populations associated with higher uncertainty on the evidence-base for approval and reimbursement decision-making…

In an effort to illuminate and discuss the challenging aspects of clinical trials in oncology, a free webinar titled “Innovating Oncology Trials: Breaking Access Barriers, Optimizing Protocols and Navigating Regulatory Challenges” is set to take place.

This webinar aims to shed light on three challenging aspects of clinical trials in oncology: The need for innovative study design for novel therapies; Patient access and diversity; And navigating the ever-changing regulatory landscape.

These topics have become increasingly important as the continued development of precision medicines has led to smaller study populations associated with higher uncertainty on the evidence-base for approval and reimbursement decision-making, while at the same time broad patient access and the external validity of the data need to be ensured. This force-field warrants clever thinking about study design and making adequate use of the evolving regulatory environment.

The webinar features a distinguished panel of speakers from ProPharma, all of whom bring a wealth of experience and knowledge to the table. The speakers include Robert Rachford, Vice President of Biostatistics and Programming; Kimberly Futch, Director of Clinical Operations Strategy; Shelby Stillwagon, Sr Director of Decentralized Clinical Trials; and Paula van Hennik, Clinical Group Head of Regulatory Sciences.

Through case studies and detailed discussions, the webinar promises to offer valuable insights into the intricacies of oncology trials, including those related to personalized medicine, immunotherapies and targeted treatments.

ProPharma, a leading Research Consulting Organization (RCO) in the pharmaceutical industry with a strong focus on oncology, is partnering with Xtalks in hosting this important event.

The free webinar is scheduled for Tuesday, July 11, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Innovating Oncology Trials: Breaking Access Barriers, Optimizing Protocols and Navigating Regulatory Challenges.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

The Innovation Imperative for Growth Stage Companies, Upcoming Webinar Hosted by Xtalks


These experts will discuss critical elements of commercialization including fundraising, user needs evaluation, human-centered design and iterative prototyping.

An exciting, free webinar in the medical device industry is set to happen, with insights into innovation strategies for growth-stage companies to be shared by some of the industry’s most experienced professionals. This webinar will provide an opportunity for attendees to hear from founders, CEOs and executives about the importance of innovation for growth-stage companies and gain valuable insights into strategies for bringing differentiated medical devices to market.

The webinar, titled “Medical Technology: The Innovation Imperative for Growth Stage Companies,” is being moderated by Brandon Bogdalek, Vice President of Demand Generation at Veranex, a healthcare product innovation and commercialization partner known for its human-centered design and deep engineering capability. Bogdalek, with his wealth of experience in outsourced innovation and commercialization projects, will guide the conversation with three industry-leading panelists.

The panel comprises Michael Hill, Global Head of Science & Technology and Innovation at Science Innovations L.L.C. and Adjunct Associate Professor at the Case Western Reserve University School of Engineering and Weatherhead School of Management; Nancy Schoenbrunner, Chief Executive Officer of AmplifiDx; and Tom Burke, Partner and Founder of Vail Scientific. These experts will discuss critical elements of commercialization including fundraising, user needs evaluation, human-centered design and iterative prototyping.

Veranex partnered with Xtalks for this webinar. Veranex is renowned for its fully integrated concept-to-commercialization solution in medical technology product development, boasting ISO 13485-certification, FDA-registration and over 30 years of experience. This partnership with Xtalks, a leader in providing educational webinars across various industries, aligns with their shared mission of promoting new thinking and developing the future of MedTech.

Don’t miss this chance to gain insights from industry leaders on innovation in the medical device sector. The webinar is scheduled for Friday, July 14, 2023, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Medical Technology: The Innovation Imperative for Growth Stage Companies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Meperia Continues to Boost Security Posture with Successful Completion of SOC 2® Type 2 Examination


News Image

Meperia, a cost management and revenue enhancement solutions provider focused on the healthcare supply chain, announced today it has successfully completed its System and Organizational Controls SOC 2® Type 2 examination on controls relevant to Security, Availability, and Confidentiality for its Strategic Sourcing platform.

Developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2® Type 2 examination provides reasonable assurance to users about the suitability of the design of the company’s controls placed into operation along with their operating effectiveness against the relevant Trust Services Criteria for a period of time.

“Our technology provides a competitive advantage, but it is the peace of mind we offer customers backed by the SOC 2 report that truly demonstrates our unwavering dedication to compliance solutions,” said Tom Frith, Executive Vice President. “We take pride in granting them the reassurance they deserve.”

Meperia chose 360 Advanced, Inc., a licensed CPA firm, to perform the demanding third-party SOC examination.

“The SOC 2 Type 2 takes us through a detailed review of the past year, reviewing our policies and procedures to verify that our work conforms to the standards we set,” said Michael Hannemann, VP of Technology. “We appreciate the guidance from 360 Advanced to navigate through this process.”

About Meperia

Meperia is the first supply chain content enabler to bring predictive intelligence solutions to the healthcare market. Our patented artificial intelligence imitates the ease of consumer on-line shopping. Meperia’s SaaS-based solution puts controls and real-time visibility around an organization’s spend at the point of requisitioning to ensure every purchase is on contract, on price and on target to their product formulary goals—before users buy! As visionaries, our industry firsts include data normalization, content management solutions, and our new implant management solution. Learn more at meperia.com.

For Meperia inquiries, please contact:

Leslie Haan, Director of Marketing

563-581-4604

lhaan@meperia.com

About 360 Advanced

360 Advanced is Making Better Businesses through their client-centric cybersecurity and compliance offerings. For nearly 20 years, 360 Advanced has delivered integrated compliance solutions to a global base of clients in a wide range of industries, from tech startups to the Fortune 500. Their cybersecurity and compliance offerings include ISO 27001, HITRUST, SOC, Penetration Testing, Risk Assessments, and more. To learn more about their services, visit 360 Advanced.

For more information on compliance solutions, please contact Patrick Tolliver:

ptolliver@360advanced.com.

Media Contact: Julie Butterfield

jbutterfield@360advanced.com

Share article on social media or email:

CS Analytical Laboratory Announces Notable Achievements for 2023


News Image

We must continue to develop programs and services that enable clients to meet the ever-changing and often complicated regulatory requirements for their container and package systems.

CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is excited to announce a variety of notable achievements that have taken place over the first half of 2023.

“To remain relevant and deliver value to the marketplace, we must continue to develop programs and services that enable clients to meet the ever-changing and often complicated regulatory requirements for their container and package systems. The CS Analytical Team is committed to this endeavor by making it our mission to share our experience, knowledge and commitment to regulatory compliance with each client and bring an “exceeds expectations” level of service to each test program,” noted CEO Brian Mulhall.

The CS Analytical Team offers comprehensive CCI method development, validation, and analysis, as well as USP/EP/JP physical performance tests and physicochemical tests for all common or unique primary packaging components and systems. In addition, CS Analytical offers a host of support and complimentary testing programs that ensure all aspects of the regulatory requirements are met for any type of container system. Whether a unique product storage device or a challenging and oversize IV bag system, the CS Analytical Team has the knowledge and hands-on experience to develop a qualification test program that ensures all regulatory compliance factors are met.

About CS Analytical Laboratory

The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and the thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic and elastomers as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Share article on social media or email:

Ocean Tomo, a part of J.S. Held Cannabis Industry Report Reveals Industry Expansion Despite Banking, Legal and Regulatory Roadblocks


News Image

The Ocean Tomo Cannabis Industry Report pairs unique insights related to the science, technology, regulatory, banking, and intellectual property considerations impacting cannabis business value.

Ocean Tomo, a part of J.S. Held, releases its Cannabis Industry Report exploring the intellectual property (IP) protection limitations, legal & banking challenges and regulatory complexity facing the Cannabis Industry. The report is available for download here: https://oceantomo.com/download-cannabis-report/.

Cannabis continues to struggle in the public markets. “Top players in the cannabis market underperformed the S&P and the Dow in 2022 and 2023, with significantly higher volatility; market uncertainty spurred by inconsistent legal status, regulations, and banking challenges are creating a challenging environment for public company performance”, noted Transaction Advisory Managing Director, Ryan Zurek.

Cannabis mergers and acquisitions (M&As) reflect challenges faced by the industry. Larger deals face mounting challenges such as rising acquisition costs, regulatory hurdles, and an overinflated market where sellers remain emotionally attached to outdated valuations. In contrast, smaller deals present opportunities for cannabis entrepreneurs to enter new markets, either geographically or through ancillary businesses. Ocean Tomo Cannabis Industry Analyst Cameron Pirochta cites industry insiders who expect to witness a surge in smaller deals within the cannabis market in 2023. He adds, “Fierce competition and a progressively challenging business climate compel cannabis entrepreneurs to consider selling their distressed businesses.”

J.S. Held compliance and receivership management technical expert Paula Durham notes, “Due to the federal illegality of cannabis, U.S. bankruptcy courts do not protect cannabis-related businesses (CRBs), making state court receiverships a viable alternative for distressed CRBs. Receiverships can address business insolvency, serve as a temporary solution during legal disputes, and provide stability while litigation proceeds or a restructuring plan is developed.”

Securing intellectual property in the cannabis industry is challenging due to federal illegality.

Despite this challenge, intellectual property has emerged as an important factor in cannabis M&As. A notable example is British American Tobacco’s recent acquisition of a nearly 20% stake in the Canadian cannabis producer Organigram for $175 million. The acquisition aims to develop core intellectual property for cannabinoid-based products and delivery systems, emphasizing the significance of product innovation and fundamental research and development (R&D) in gaining a competitive edge within the cannabis industry.

Despite federal roadblocks, cultural acceptance, expanded pharmacological use, progressive state-level deregulation, and support from Acannability, the industry’s first member-driven, direct-to-consumer, and supply chain advertising cooperative, the cannabis industry continues to expand at an impressive rate.

Daniel Principe, who oversees the Industry Reports, shares, “the Cannabis Industry report demonstrates how Ocean Tomo’s intellectual property analyses and insights can be further strengthened when paired with technical experts in the relevant industry. As our IP professionals continue to collaborate with J.S. Held technical experts, our clients and Industry Reports readers will continue to benefit.” In 2018, a series of Industry Analyst Reports were launched to provide a comprehensive look at current industry trends and deal activity. Our reports currently examine the following industries: Autonomous, Battery, Blockchain & Cryptocurrency, Cannabis, Cybersecurity, IP Licensing Companies, and Semiconductors.

To learn more, download the Cannabis Industry Report or contact:

Cameron Pirochta | Cannabis Analyst | +1 312 377 8032 | cameron.piochta@jsheld.com

Paula Durham | Director, Corporate Finance | +1 602 279 7505 | pdurham@jsheld.com

Daniel Principe |Manager, Valuation & IP Strategy | +1 312 377 4426 | daniel.principe@jsheld.com

About Ocean Tomo, a part of J.S. Held

Established in 2003, Ocean Tomo provides Financial Expert, Management Consulting, and Advisory Services related to intellectual property (IP) and other intangible assets; corporate accounting investigations; regulatory and reporting obligations; solvency and restructuring; and contractual or competition disputes. Practice offerings address economic damage calculations and testimony; accounting investigations and financial forensics; technology and intangible asset valuation; strategy and risk management consulting; mergers and acquisitions; debt and equity private placement; and IP brokerage. Subsidiaries of Ocean Tomo include Ocean Tomo Investments Group, LLC, a registered broker-dealer.

As a part of J.S. Held, Ocean Tomo works alongside more than 1500 professionals globally and assists clients – corporations, insurers, law firms, governments, and institutional investors – on complex technical, scientific, and financial matters across all assets and value at risk.

J.S. Held is a global consulting firm providing technical, scientific, and financial expertise across all assets and value at risk. Our professionals serve as trusted advisors to organizations facing high-stakes events demanding urgent attention, staunch integrity, clear-cut analysis, and an understanding of both tangible and intangible assets. The firm provides a comprehensive suite of services, products, and data that enable clients to navigate complex, contentious, and often catastrophic situations.

Share article on social media or email:

Next Level Medical Partners with PharmaPoint to Drive Medication Optimization


PharmaPoint

Integration of this tool into our workflow increases the quality of care for our patients, all while lowering the cost of care. It’s a win/win scenario.

Next Level Medical is the newest partner to choose PharmaPoint’s XchangePoint platform to optimize medication treatment plans for patients under their care.

The partnership will target Next Level PRIME members plus their spouses and dependents that have been diagnosed with diabetes, hypertension or high cholesterol. XchangePoint’s MedTransition platform will proactively help identify patients that are nonadherent or have potential interactions with their drug treatment plan.

“XchangePoint is going to be the tool that allows us to prioritize our high-risk patients and monitor critical extended care touchpoints around medication adherence, potential drug interactions, duplicate therapies and drug/allergy interactions,” says Dr. Juliet Breeze, CEO of Next Level Medical, LLC. “Integration of this tool into our workflow increases the quality of care for our patients, all while lowering the cost of care. It’s a win/win scenario.”

Next Level PRIME members plus their spouses and dependents have unlimited access to Next Level locations seven days a week for primary, preventive, chronic and urgent care needs. Licensed Registered Nurses (RNs) are available by phone day and night to answer health questions and schedule appointments. PRIME members also have access to around the clock telemedical and virtual visits along with health and wellness coaching and behavioral health and emotional wellness counseling. Additionally, with PRIME, members have access to a full scope of high-quality care, including blood draws, lab testing, vaccines/immunizations and health screenings.

“I have always had an enormous amount of respect for Dr. Breeze,” says Mike Plaia, CEO of PharmaPoint. “She and her leadership team use a visionary care model to offer patients a seamless experience through the continuum of their healthcare journey. Partnering with an organization committed to providing excellent value-based care by removing any barriers that can occur between the provider and patient is the perfect collaborative effort for us. We are confident that our XchangePoint platform will further enable them to meet their goals.”

About PharmaPoint

PharmaPoint is an innovative, technology-enabled pharmacy management and software company. XchangePoint, our proprietary integrated workflow management system supporting medication management across care transitions, is designed for pharmacy and care team members to drive medication optimization for at-risk patients in the acute, post-acute and ambulatory care settings. Additionally, through the management of outpatient retail pharmacies for hospitals, health systems and physician groups, our commitment to completing the care continuum results in improved patient health and satisfaction, reduced healthcare costs, and provides clients with a source of ancillary income. Headquartered in Birmingham, Ala., PharmaPoint has been recognized as one of the most innovative, inspiring and fastest growing private companies for six consecutive years by Inc. Magazine. For more information about our company, please visit http://www.pharmapoint.com.

About Next Level Medical, LLC

Next Level Urgent Care was founded on the belief that it is possible to provide high-quality, cost-effective medical care for all who need immediate attention for non-life-threatening illnesses and injuries. As the first organization in Texas to achieve Urgent Care Center Accreditation through the American Academy of Urgent Care Medicine (AAUCM), a voluntary evaluation that measures the quality of services and performance against nationally recognized standards, Next Level Urgent Care clinics provide an excellent alternative for the treatment of sprains, strains, fractures, lacerations, allergies, rashes and congestion issues. Unlike retail walk-in clinics, all Next Level facilities have x-ray equipment on site and employ providers who are procedurally trained to handle acute urgent medical conditions that are not life-threatening. With convenient locations throughout the Houston, San Antonio, and Austin areas, clinics are open seven days a week until 9 p.m. For more information, please visit http://www.nextlevelurgentcare.com.

####

Share article on social media or email:

Red House Wellness Announces Upcoming Retreats for July and September in Beautiful Park City, UT


News Image

I came to this retreat because I needed to heal from a recent break up, as well as from my divorce, to find the joy in my life again … I am now planning to create the life I want!

Red House Wellness, a premier holistic retreat center, is excited to announce its upcoming transformative retreats designed to rejuvenate your body, mind, and soul. Set against the backdrop of serene natural surroundings, Red House Wellness invites individuals seeking a revitalizing escape to join us on July 16th or September 10th for an unforgettable experience.

“At Red House Wellness, we believe in the power of self-care and the importance of reconnecting with our inner selves,” says Sherri Lukac, founder of Red House Wellness. “Our retreats are meticulously designed to provide a haven for relaxation, reflection, and personal growth. We are dedicated to helping individuals achieve holistic wellness, and we’re thrilled to offer these transformative experiences on July 16th and September 10th.”

During the retreat, guests will have the opportunity to:

  • Explore Mindful Practices: Engage in guided meditation sessions, mindful movement classes, and breathwork exercises, fostering a deep sense of inner peace.
  • Indulge in Restorative & Vitalizing Therapies: Experience the healing powers of our rejuvenating on-site sauna and different yoga styles in our heated yoga room.
  • Immerse in Nature: Surround yourself with the natural beauty of our retreat center and take part in nature hikes, paddle-board yoga and a visit wild horse sanctuary.
  • Nourish with a Balanced Cuisine: Delight in wholesome, plant-based, and locally sourced meals prepared by our expert chef, nourishing both the body and the soul.

Carla Calabrese attended Red House Wellness this year and has this to say:

“I first-hand experienced the change in myself, and I observed and listened to the testimonials on the last day of the other 5 guests (aka, my new life-long friends), who also experienced major changes in their outlooks, attitudes, happiness, and well-being. I came to this retreat because I needed to heal from a recent break up, as well as from my divorce, to find the joy in my life again … I am now planning to create the life I want!”

To learn more about Red House Wellness’ retreats, check out the resources below:

About Red House Wellness

Red House Wellness is an intimate retreat providing transformative experiences for individuals seeking balance, self-care, growth, and a reset. Through a holistic approach to care from exceptional program leaders, people leave their one-week experience at Red House Wellness feeling energized, focused, and motivated to live as the very best version of themselves.

Share article on social media or email: